Cases are rising in the DRC, and countries around it are tightening border measures. Are those efforts meeting soon enough? If you're just joining us, here's where we were before this report: the DRC Bundibugyo outbreak had reached six provinces, with 6,342 laboratory-confirmed cases and 3,072 deaths by September 2. A confirmed case in AFC/M23-controlled Kayna kept surveillance and contact-tracing concerns alive in rebel-held North Kivu, while responders also faced gaps in strain-specific medical tools and access. This is Ebola Watch. We start with what the latest DRC numbers actually tell us, then turn to vaccines with a serious scientific question hanging over them and a new cross-border deal. From NAMPA:
The number of confirmed Ebola cases in the Democratic Republic of the Congo (DRC) has risen to 6,604, with 3,175 deaths reported, the DRC National Institute of Public Health (INSP) said on Monday. "Over the past 24 hours, 82 new cases and 41 deaths have been recorded. The total number of cases since the start of the outbreak has reached 6,604, with 3,175 deaths," the statement read.
INSP now puts the DRC Bundibugyo outbreak at 6,604 confirmed cases, with 3,175 deaths. That label matters; the category has too often been blurry. And the 24-hour snapshot is hard to wave away: 82 new confirmed cases, 41 deaths. If that pace ran for a week, you'd be talking about hundreds more families hearing this news. Yes—with one caveat. A single day is a rate, not a forecast. Reports can bunch up. But 41 deaths reported in 24 hours is a severe signal, and it deserves to be said plainly. Half as many deaths as new cases in one reported day. For a traveler or a family with someone working there, that changes how this feels fast—even if it doesn't tell us what their personal risk is. Africa Defense Forum writes:
The outbreak is now considered the fastest-growing one yet in the DRC, according to the World Health Organization (WHO), although the true extent of the outbreak is not known. It was declared on May 15, but the WHO says sequencing showed it began in February. The West African Ebola outbreak killed 11,325 people from 2014 to 2016.
Fifty thousand Ervebo doses are going to frontline workers, with another 20,000 set aside for a clinical trial. But Ervebo was developed for Zaire ebolavirus, and this outbreak is Bundibugyo. So are we giving people a vaccine whose protection here is still unproven? We have to keep that uncertainty in view, even as the doses arrive. Getting them to nurses and burial teams matters. But calling it confirmed protection against Bundibugyo would go beyond the evidence. And ADF says up to 70 percent of new cases are being recorded outside contact-tracing areas. You can't ring-vaccinate contacts you haven't found. Exactly. WHO's sequencing says circulation goes back to February, though the outbreak was declared May 15. The 50,000-dose operation also needs surveillance, safe burials, water, and access—or cases will keep appearing where the response can't reach. Here's East African Vanguard:
JUBA – South Sudan and Uganda have signed a Memorandum of Understanding (MOU) to strengthen cross-border cooperation in preventing and responding to disease outbreaks and other public health emergencies. The agreement, signed in Juba on Monday 7th, 2026 by the two countries’ health ministers, establishes a framework for joint surveillance, information sharing and coordinated preparedness and response to health emergencies along their shared border.
South Sudan and Uganda signed the agreement in Juba on September 7. It calls for joint surveillance, outbreak notification, contact tracing, and harmonized border screening. Those are the nuts and bolts of making a border part of the response. And at a crossing, that means a flagged traveler shouldn't just become Uganda's problem or South Sudan's problem. The people behind them in line need screening, their contacts need to be followed across the border, and the two health ministries need to be talking that day. Exactly. Ministers Luke Thompson Thoan Teny and Chris Baryomunsi have put a formal channel behind that work—biospecimen transfer and mobile teams included. A signed MOU is only the start; its value comes down to how quickly those systems move when an alert arrives. From Andrino Kangela at AVSI:
While the Ebola outbreak expands across six provinces, AVSI with funds from the Italian Cooperation is working with health facilities and communities in North and South Kivu to improve surveillance, infection prevention and access to essential health services.
AVSI says REACT is working in North and South Kivu, while confirmed cases have reached 57 health zones across six provinces. Is that surveillance reaching the places people are moving through—or only the facilities they can safely get to? And conflict is at the center of this. Displacement makes contact tracing harder, while those same clinics handling Ebola still have to deliver babies and treat malaria. Infection prevention can't become a single-disease service. I want a practical answer on labs, too. REACT says it's doing surveillance in the Kivus—does that include faster access to testing, or are workers identifying possible cases and then waiting on a machine somewhere else? That detail decides how much the project can actually change transmission. AVSI is covering 57 health zones, but preparedness has to work clinic by clinic—especially for displaced families with the least room to absorb a delay. If you’re finding Ebola Watch useful, please subscribe or leave us a review wherever you’re listening. Reviews help other people find the show.
Links to every story are in the show notes if you want to dig into anything we covered. Thanks for listening, and we’ll be back tomorrow. That’s Ebola Watch for today. This is a Lantern Podcast.